These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 37510143)

  • 21. Evolving molecular era of childhood medulloblastoma: time to revisit therapy.
    Khatua S
    Future Oncol; 2016 Jan; 12(1):107-17. PubMed ID: 26617331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex differences in methylation profiles are apparent in medulloblastoma, particularly among SHH tumors.
    Moss RM; Sorajja N; Mills LJ; Moertel CL; Hoang TT; Spector LG; Largaespada DA; Williams LA
    Front Oncol; 2023; 13():1113121. PubMed ID: 37035203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical implications of medulloblastoma subgroups.
    Northcott PA; Korshunov A; Pfister SM; Taylor MD
    Nat Rev Neurol; 2012 May; 8(6):340-51. PubMed ID: 22565209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. G-protein coupled receptor expression patterns delineate medulloblastoma subgroups.
    Whittier KL; Boese EA; Gibson-Corley KN; Kirby PA; Darbro BW; Qian Q; Ingram WJ; Robertson T; Remke M; Taylor MD; O'Dorisio MS
    Acta Neuropathol Commun; 2013 Oct; 1():66. PubMed ID: 24252460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advanced MRI Findings in Medulloblastomas: Relationship to Genetic Subtypes, Histopathology, and Immunohistochemistry.
    Reis J; Stahl R; Zimmermann H; Ruf V; Thon N; Kunz M; Liebig T; Forbrig R
    J Neuroimaging; 2021 Mar; 31(2):306-316. PubMed ID: 33465267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of different molecular subtypes and tumor biology on the prognosis of medulloblastoma.
    Aras Y; Dölen D; İribas Çelik A; Kılıç G; Kebudi R; Ünverengil G; Sabancı PA; İzgi AN
    Childs Nerv Syst; 2021 Dec; 37(12):3733-3742. PubMed ID: 34550414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New Developments in the Pathogenesis, Therapeutic Targeting, and Treatment of Pediatric Medulloblastoma.
    Fang FY; Rosenblum JS; Ho WS; Heiss JD
    Cancers (Basel); 2022 May; 14(9):. PubMed ID: 35565414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medulloblastoma: Molecular understanding, treatment evolution, and new developments.
    Liu X; Ding C; Tan W; Zhang A
    Pharmacol Ther; 2020 Jun; 210():107516. PubMed ID: 32105673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subgroup-Specific Diagnostic, Prognostic, and Predictive Markers Influencing Pediatric Medulloblastoma Treatment.
    Ray S; Chaturvedi NK; Bhakat KK; Rizzino A; Mahapatra S
    Diagnostics (Basel); 2021 Dec; 12(1):. PubMed ID: 35054230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exclusive Hyperfractionated Radiation Therapy and Reduced Boost Volume for Standard-Risk Medulloblastoma: Pooled Analysis of the 2 French Multicentric Studies MSFOP98 and MSFOP 2007 and Correlation With Molecular Subgroups.
    Carrie C; Kieffer V; Figarella-Branger D; Masliah-Planchon J; Bolle S; Bernier V; Laprie A; Supiot S; Leseur J; Habrand JL; Alapetite C; Kerr C; Dufour C; Claude L; Chapet S; Huchet A; Bondiau PY; Escande A; Truc G; Nguyen TD; Pasteuris C; Vigneron C; Muracciole X; Bourdeaut F; Appay R; Dubray B; Colin C; Ferlay C; Dussart S; Chabaud S; Padovani L; ;
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1204-1217. PubMed ID: 32768563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Updates on Management of Adult Medulloblastoma.
    Majd N; Penas-Prado M
    Curr Treat Options Oncol; 2019 Jun; 20(8):64. PubMed ID: 31236711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disease-associated KBTBD4 mutations in medulloblastoma elicit neomorphic ubiquitylation activity to promote CoREST degradation.
    Chen Z; Ioris RM; Richardson S; Van Ess AN; Vendrell I; Kessler BM; Buffa FM; Busino L; Clifford SC; Bullock AN; D'Angiolella V
    Cell Death Differ; 2022 Oct; 29(10):1955-1969. PubMed ID: 35379950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case-based review: pediatric medulloblastoma.
    Kline CN; Packer RJ; Hwang EI; Raleigh DR; Braunstein S; Raffel C; Bandopadhayay P; Solomon DA; Aboian M; Cha S; Mueller S
    Neurooncol Pract; 2017 Sep; 4(3):138-150. PubMed ID: 29692919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid diagnosis of medulloblastoma molecular subgroups.
    Schwalbe EC; Lindsey JC; Straughton D; Hogg TL; Cole M; Megahed H; Ryan SL; Lusher ME; Taylor MD; Gilbertson RJ; Ellison DW; Bailey S; Clifford SC
    Clin Cancer Res; 2011 Apr; 17(7):1883-94. PubMed ID: 21325292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medulloblastoma under Siege: Genetic and Molecular Dissection Concerning Recent Advances in Therapeutic Strategies.
    Rawal ZD; Upadhyay VA; Patel DD; Trivedi TI
    J Pediatr Neurosci; 2020; 15(3):175-182. PubMed ID: 33531929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Digital expression profile of immune checkpoint genes in medulloblastomas identifies CD24 and CD276 as putative immunotherapy targets.
    Marques RF; Moreno DA; da Silva L; Leal LF; de Paula FE; Santana I; Teixeira G; Saggioro F; Neder L; Junior CA; Mançano B; Reis RM
    Front Immunol; 2023; 14():1062856. PubMed ID: 36825029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medulloblastoma: an Old Diagnosis with New Promises.
    Szalontay L; Khakoo Y
    Curr Oncol Rep; 2020 Jul; 22(9):90. PubMed ID: 32643099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic profiling of medulloblastoma reveals novel proteins differentially expressed within each molecular subgroup.
    Narayan V; Jaiswal J; Sugur H; Sd S; Rao S; Chatterjee A; Gowda H; A A; Somanna S; Santosh V
    Clin Neurol Neurosurg; 2020 Sep; 196():106028. PubMed ID: 32580068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medulloblastoma and the DNA Damage Response.
    McSwain LF; Parwani KK; Shahab SW; Hambardzumyan D; MacDonald TJ; Spangle JM; Kenney AM
    Front Oncol; 2022; 12():903830. PubMed ID: 35747808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune microenvironment of medulloblastoma: The association between its molecular subgroups and potential targeted immunotherapeutic receptors.
    Kurdi M; Mulla N; Malibary H; Bamaga AK; Fadul MM; Faizo E; Hakamy S; Baeesa S
    World J Clin Oncol; 2023 Mar; 14(3):117-130. PubMed ID: 37009528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.